Open house Arzneimittelrabattverträge zum Wirkstoff Interferon beta-1a, intramuskuläre Injektion, ATC L03AB07

TENDER DESCRIPTION

The AOK Rheinland-Pfalz/Saarland - The Health Insurance Fund offers all interested pharmaceutical companies rebate contracts for the above-mentioned active substance without selection decision. Contract conclusions take place within the framework of an "Open House Model". The contracts offered are non-exclusive; contracts with all market participants (pharmaceutical companies) are desired by AOK Rheinland-Pfalz/Saarland - The Health Insurance Fund. Uniform conditions apply to all participants in the Open House model. Contract contents, conditions, and access procedures are uniform - individual negotiations are not conducted. The contract durations are a maximum of 24 months; the earliest contract start date is 01.09.2026. All contracts end at the latest 24 months after the day of the earliest contract start, regardless of the date of the respective contract conclusion. Joining or contract conclusion can take place within the 24-month period on the first day of each month. There is a right of termination six weeks prior to the end of a month in accordance with the provisions of the contract. Further information on termination options is included in the contract documents. AOK…

TENDER BRIEF

TENDER DOCUMENTS